Abbott Laboratories reports results for the quarter ended March 31 - Earnings Summary

• Abbott Laboratories ABT.N reported quarterly adjusted earnings of $1.09​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 98 cents. The mean expectation of twenty three analysts for the quarter was for earnings of $1.07 per share. Wall Street expected results to range from $1.05 to $1.09 per share.

• Revenue rose 4% to $10.36 billion from a year ago; analysts expected $10.40 billion.

• Abbott Laboratories's reported EPS for the quarter was 76 cents​.

• The company reported quarterly net income of $1.33 billion.

• Abbott Laboratories shares had fallen by 4.8% this quarter and gained 11.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 3.9% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 19 "strong buy" or "buy," 9 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

• Wall Street's median 12-month price target for Abbott Laboratories is $135.00

This summary was machine generated from LSEG data April 16 at 01:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)